| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |